Seelos Therapeutics, Inc. (Nasdaq: SEEL) (“Seelos”), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that its 2024 Annual Meeting of Stockholders (the “Annual Meeting”), which was originally scheduled to be held on September 27, 2024, has been postponed. The Annual Meeting is now […]
Vail Resorts, Inc. (NYSE: MTN) today reported results for the fourth quarter and fiscal year ended July 31, 2024 and reported results of season-to-date pass product sales. Vail Resorts also provided its outlook for the fiscal year ending July 31, 2025, announced a $100 million multi-year resource efficiency transformation plan, declared a dividend payable in
AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, has been awarded a five-year indefinite delivery / indefinite quantity contract with an aggregate ceiling value of approximately $1.2 billion by the U.S. Navy’s Naval Air Systems Command (NAVAIR) to perform engine depot maintenance and repair for
CGTN America & CCTV UN releases “My China Story: the Future Youth Leaders Forum” As we approach the 75th anniversary of the founding of the People’s Republic of China, a special event to be presented by the China Media Group and the Bank of China USA will highlight the country’s commitment to peace, progress through
NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) — Hennessy Capital Investment Corp. VI (NASDAQ: HCVI) (the “Company”) today announced that its special meeting of the stockholders (the “Meeting”) will be postponed from 10:00 a.m. Eastern Time on September 27, 2024 to 10:00 a.m. Eastern Time on September 30, 2024. The record date for determining the
At first-ever Flywire Fusion event, Flywire’s momentum in solving cross-border and domestic payments challenges was on full display More than 100 U.S. institutions are powered by the full-suite or solutions of Flywire’s Student Financial Software, which is delivering meaningful ROI Product leaders and industry experts share strategies to improve retention, drive recruitment and optimize student
Venlo, the Netherlands, Sept. 26, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QIAstat-Dx syndromic testing systems and associated assays have received CE-marking under the European Union’s new In-Vitro Diagnostic Medical Devices Regulation (IVDR). This certification includes the widely-used QIAstat-Dx Analyzer, QIAstat-Dx Rise, and panels for detecting gastrointestinal
New Istaroxime Phase 2b clinical results to be presented by Windtree and top cardiology expert Review of cardiogenic shock and other programs, including Windtree’s strategy and planned near-term milestones WARRINGTON, Pa., Sept. 26, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage
NORWELL, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today
CHICAGO, Sept. 26, 2024 (GLOBE NEWSWIRE) — MondelÄ”z International (Nasdaq: MDLZ) today announced the launch of a new platform designed to improve its global marketing capabilities while optimizing consumer experiences through expanded use of artificial intelligence (AI) and generative AI (gen AI). Working in collaboration with Accenture (NYSE: ACN) and Publicis Groupe, the company’s new